1 asset in Granulosa Cell Tumor
Therapeutic assets addressing Granulosa Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nivolumab Granulosa Cell Tumor | Instituto do Cancer do Estado de São Paulo | P2 | CCC (53) |